Cargando…
Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study
BACKGROUND: Extracorporeal shock wave therapy (ESWT) is a widely considered treatment option for Achilles tendinopathy. Line-focused ESWT is a novel technique treating a larger tendon area than point-focused ESWT. Monitoring capacities of clinical symptoms with ultrasound under ESWT treatment are un...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404720/ https://www.ncbi.nlm.nih.gov/pubmed/33586526 http://dx.doi.org/10.1177/1941738121991791 |
_version_ | 1783746219897520128 |
---|---|
author | Gatz, Matthias Schweda, Sebastian Betsch, Marcel Dirrichs, Timm de la Fuente, Matias Reinhardt, Nina Quack, Valentin |
author_facet | Gatz, Matthias Schweda, Sebastian Betsch, Marcel Dirrichs, Timm de la Fuente, Matias Reinhardt, Nina Quack, Valentin |
author_sort | Gatz, Matthias |
collection | PubMed |
description | BACKGROUND: Extracorporeal shock wave therapy (ESWT) is a widely considered treatment option for Achilles tendinopathy. Line-focused ESWT is a novel technique treating a larger tendon area than point-focused ESWT. Monitoring capacities of clinical symptoms with ultrasound under ESWT treatment are unknown. HYPOTHESIS: Point- and line-focused ESWT have a superior outcome than placebo ESWT. ESWT leads to morphological tendon changes detectable with ultrasound. STUDY DESIGN: Single-blinded placebo-controlled randomized contolled trial. LEVEL OF EVIDENCE: Level 1. METHODS: The study was conducted in 3 cohorts, namely ESWT point (n = 21), ESWT line (n = 24), and ESWT placebo (n = 21). Victorian Institute of Sports Assessment–Achilles (VISA-A) score was measured before the intervention (T0), after 6 weeks (T1), and after 24 weeks (T2). All cohorts performed daily physiotherapy for 24 weeks and received 4 sessions of point-focused, line-focused, or placebo ESWT in the first 6 weeks. Ultrasound was performed with B-mode, power Doppler, shear wave elastography (SWE) at T0 and T2 and with ultrasound tissue characterization (UTC) at T0, T1, and T2. Data were analyzed with a mixed analysis of variance and t test. RESULTS: There was a significant VISA-A improvement over time for all groups (P < 0.001). ESWT point had the strongest VISA-A score improvement +23 (ESWT line: +18; ESWT placebo: +15), but there was no significant interaction between time and any of the groups: F(4, 116) = 1.393; P = 0.24. UTC, power Doppler, and B-mode could not show significant alterations over time. SWE revealed a significant increase of elastic properties for ESWT point in the insertion (t = −3.113, P = 0.03) and midportion (t = −2.627, P = 0.02) over time. CONCLUSION: There is a significant VISA-A score improvement for all study groups without a statistically significant benefit for ESWT point or ESWT line compared with ESWT placebo. Tendon adaptation could only be detected with SWE for ESWT point. CLINICAL RELEVANCE: The present study could not detect any statistically relevant effect of ESWT compared to placebo. SWE is able to demonstrate tendon adaptation. |
format | Online Article Text |
id | pubmed-8404720 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-84047202021-09-02 Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study Gatz, Matthias Schweda, Sebastian Betsch, Marcel Dirrichs, Timm de la Fuente, Matias Reinhardt, Nina Quack, Valentin Sports Health Current Research BACKGROUND: Extracorporeal shock wave therapy (ESWT) is a widely considered treatment option for Achilles tendinopathy. Line-focused ESWT is a novel technique treating a larger tendon area than point-focused ESWT. Monitoring capacities of clinical symptoms with ultrasound under ESWT treatment are unknown. HYPOTHESIS: Point- and line-focused ESWT have a superior outcome than placebo ESWT. ESWT leads to morphological tendon changes detectable with ultrasound. STUDY DESIGN: Single-blinded placebo-controlled randomized contolled trial. LEVEL OF EVIDENCE: Level 1. METHODS: The study was conducted in 3 cohorts, namely ESWT point (n = 21), ESWT line (n = 24), and ESWT placebo (n = 21). Victorian Institute of Sports Assessment–Achilles (VISA-A) score was measured before the intervention (T0), after 6 weeks (T1), and after 24 weeks (T2). All cohorts performed daily physiotherapy for 24 weeks and received 4 sessions of point-focused, line-focused, or placebo ESWT in the first 6 weeks. Ultrasound was performed with B-mode, power Doppler, shear wave elastography (SWE) at T0 and T2 and with ultrasound tissue characterization (UTC) at T0, T1, and T2. Data were analyzed with a mixed analysis of variance and t test. RESULTS: There was a significant VISA-A improvement over time for all groups (P < 0.001). ESWT point had the strongest VISA-A score improvement +23 (ESWT line: +18; ESWT placebo: +15), but there was no significant interaction between time and any of the groups: F(4, 116) = 1.393; P = 0.24. UTC, power Doppler, and B-mode could not show significant alterations over time. SWE revealed a significant increase of elastic properties for ESWT point in the insertion (t = −3.113, P = 0.03) and midportion (t = −2.627, P = 0.02) over time. CONCLUSION: There is a significant VISA-A score improvement for all study groups without a statistically significant benefit for ESWT point or ESWT line compared with ESWT placebo. Tendon adaptation could only be detected with SWE for ESWT point. CLINICAL RELEVANCE: The present study could not detect any statistically relevant effect of ESWT compared to placebo. SWE is able to demonstrate tendon adaptation. SAGE Publications 2021-02-13 /pmc/articles/PMC8404720/ /pubmed/33586526 http://dx.doi.org/10.1177/1941738121991791 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Current Research Gatz, Matthias Schweda, Sebastian Betsch, Marcel Dirrichs, Timm de la Fuente, Matias Reinhardt, Nina Quack, Valentin Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study |
title | Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study |
title_full | Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study |
title_fullStr | Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study |
title_full_unstemmed | Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study |
title_short | Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study |
title_sort | line- and point-focused extracorporeal shock wave therapy for achilles tendinopathy: a placebo-controlled rct study |
topic | Current Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404720/ https://www.ncbi.nlm.nih.gov/pubmed/33586526 http://dx.doi.org/10.1177/1941738121991791 |
work_keys_str_mv | AT gatzmatthias lineandpointfocusedextracorporealshockwavetherapyforachillestendinopathyaplacebocontrolledrctstudy AT schwedasebastian lineandpointfocusedextracorporealshockwavetherapyforachillestendinopathyaplacebocontrolledrctstudy AT betschmarcel lineandpointfocusedextracorporealshockwavetherapyforachillestendinopathyaplacebocontrolledrctstudy AT dirrichstimm lineandpointfocusedextracorporealshockwavetherapyforachillestendinopathyaplacebocontrolledrctstudy AT delafuentematias lineandpointfocusedextracorporealshockwavetherapyforachillestendinopathyaplacebocontrolledrctstudy AT reinhardtnina lineandpointfocusedextracorporealshockwavetherapyforachillestendinopathyaplacebocontrolledrctstudy AT quackvalentin lineandpointfocusedextracorporealshockwavetherapyforachillestendinopathyaplacebocontrolledrctstudy |